The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of gemcitabine plus trastuzumab and pertuzumab in previously treated metastatic HER2+ breast cancer.
 
Hatem Hussein Soliman
Consulting or Advisory Role - Celgene; EMD Serono
Research Funding - Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix
 
Fatema Khambati
Research Funding - Genentech (Inst)
 
Hyo S. Han
Research Funding - Karyopharm Therapeutics (Inst)
 
Roohi Ismail-Khan
No Relationships to Disclose
 
Loretta S. Loftus
Stock and Other Ownership Interests - Lilly/ImClone
 
Susan E. Minton
No Relationships to Disclose